Tokyo, Oct. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059440) titled 'Internet Survey on Nutritional Management and Relapse Status in IBD Patients - 3R Survey' on Oct. 27.
Study Type:
Observational
Primary Sponsor:
Institute - EA Pharma
Condition:
Condition - Crohn's disease, Ulcerative colitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - An online survey of IBD patients will be conducted to assess their nutritional management practices and relapse patterns.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Individuals with Crohn's disease or ulcerative colitis who are registered in the Cross Marketing Co., Ltd. survey cooperation panel and who have agreed to participate in this survey
Key exclusion criteria - None
Target Size - 150
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 10 Month 16 Day
Date of IRB - 2025 Year 10 Month 16 Day
Anticipated trial start date - 2025 Year 11 Month 04 Day
Last follow-up date - 2025 Year 11 Month 28 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067978
Disclaimer: Curated by HT Syndication.
